CTKB Q1 2021 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$24M+34.9% YoY

Gross Profit

$14M59.7% margin

Operating Income

$1M4.7% margin

Net Income

$102,0000.4% margin

EPS (Diluted)

$0.00

QoQ Revenue Growth

-20.7%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$1M

Stock-Based Comp.

$456,000

Balance Sheet

Total Assets

$224M

Total Liabilities

$239M

Stockholders' Equity

-$15M

Cash & Equivalents

$169M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$18M	+34.9%
Gross Profit	$14M	$8M	+73.0%
Operating Income	$1M	-$710,000	+259.4%
Net Income	$102,000	-$839,000	+112.2%